Clinical Trial Update: Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is recruiting to evaluate epcoritamab in relapsed/refractory primary central nervous system lymphoma treated with lenalidomide and ritu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• EPKINLY (EPCORITAMAB-BYSP)
• Revlimid (lenalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Primary CNS Lymphoma (PCNSL) | Phase 2 | Status: RECRUITING